Figure 2From: Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study CDF of IWQoL-Lite questionnaire total score change from baseline to 24 months. CDF = cumulative distribution function; IWQOL-Lite = Impact of Weight on Quality of Life-Lite Higher scores indicate higher quality of life. IWQOL-Lite was not applied in Germany.Back to article page